Bridging the Accessibility Gap of Cannabinoid Medicine and Arabic Culture

Robinson, Dror; Ritter, Sivan; Zadik-Weiss, Lilach; Ounallah-Saad, Hadile; Abu-Ahmad, Nour; Kashkoosh, Rashid; Yassin, Mustafa; Or, Reuven

doi:10.5041/rmmj.10392

Cited by 6 publications

(3 citation statements)

References 9 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite its illegal status, exception has been made for production and use-related purposes [ 12 ]. In 2019, 2.8% of India’s population aged 10 to 75 reported cannabis use [ 13 ].…”

Section: Introductionmentioning

confidence: 99%

Foreign Medical Students in Eastern Europe: Knowledge, Attitudes and Beliefs about Medical Cannabis for Pain Management

Konstantinov

Reznik

Zangeneh

et al. 2021

IJERPH

View full text Add to dashboard Cite

Objective: To assess the knowledge, attitudes, and beliefs of foreign students toward the use of medical cannabis (MC) for pain management. Methods: This study uses data collected from 549 foreign students from India (n = 289) and Middle Eastern countries mostly from Egypt, Iran, Syria, and Jordan (n = 260) studying medicine in Russia and Belarus. Data collected from Russian and Belarusian origin medical students (n = 796) were used for comparison purposes. Pearson’s chi-squared and t-test were used to analyze the data. Results: Foreign students’ country of origin and gender statuses do not tend to be correlated with medical student responses toward medical cannabis use. Students from Russia and Belarus who identified as secular, compared to those who were religious, reported more positive attitudes toward medical cannabis and policy change. Conclusions: This study is the first to examine the attitudes, knowledge, and beliefs toward medical cannabis among foreign students from India and Middle Eastern countries studying in Russia and Belarus, two countries who oppose its recreational and medicine use. Indian and Middle Eastern students, as a group, tend to be more supportive of MC than their Russian and Belarusian counterparts. These results may be linked to cultural and historical reasons. This study provides useful information for possible medical and allied health curriculum and education purposes.

show abstract

“…Despite its illegal status, exception has been made for production and use-related purposes [ 12 ]. In 2019, 2.8% of India’s population aged 10 to 75 reported cannabis use [ 13 ].…”

Section: Introductionmentioning

confidence: 99%

Foreign Medical Students in Eastern Europe: Knowledge, Attitudes and Beliefs about Medical Cannabis for Pain Management

Konstantinov

Reznik

Zangeneh

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…For instance, as recreational use of marijuana is forbidden in Islam, despite religious scholars considering medical use of cannabis and its derivatives acceptable, cultural barriers to patients who are Muslims accepting this as a treatment option persist. 60 A survey on patient experiences with stigmatisation related to the use of medical cannabis found negative views of cannabis as a recreational drug, associated criminal sanctions, and using cannabis in the context of vulnerability (i.e., illness, disability) to be contributory to their sentiments. 61 Ideally, the increasing legalisation and normalisation of medical and recreational cannabis products throughout the world will help break down some of these barriers going forward.…”

Section: Stigmatisationmentioning

confidence: 99%

Cannabinoids in the Treatment of Epilepsy: A Review

Zhou

Dennis

Snehal

et al. 2021

EMJ

View full text Add to dashboard Cite

Cannabinoids have been studied for their role in the treatment of epilepsy for many years. The U.S. Food and Drug Administration (FDA) approved them for the treatment of some refractory syndromes in 2018. Cannabidiol and tetrahydrocannabinol are the most commonly studied cannabinoids and have been studied in great depth vis-à-vis their pharmacokinetics and pharmacodynamics. Studies have shown the efficacy of cannabinoids in the treatment of refractory epilepsy. A substantial amount of research has been performed exploring the interactions between cannabinoids and other conventional antiseizure medications. The exact mechanisms by which cannabinoids exert their effects on seizure control remain unclear and research into these mechanisms continues in great earnest. Cognitive changes from cannabinoids are constantly being studied and add to potential benefits from the use of these compounds. Cultural and social misconceptions and roadblocks about the use of cannabinoids persist and represent an ongoing obstacle to increasing research and therapeutic use of these compounds. This review focuses on all these aspects and of the use of these cannabinoids in the treatment of epilepsy and seeks to offer a fairly comprehensive description of the facets of cannabinoid therapy for refractory epilepsy.

show abstract

“…There is no objection to the use of cannabis or cannabis-derived substances for medical purposes, provided that the treatment and the eventual recovery are dependent on their use and being prescribed by a trustworthy physician. The Islam rule says, "Necessity knows no law" [5].…”

mentioning

confidence: 99%

The Use of Cannabis for Medical Purposes in the Arab World

Shirah

Ahmed

2020

Med Cannabis Cannabinoids

View full text Add to dashboard Cite

The legal landscape of cannabis (marijuana) has dramatically changed over the past few years in several countries worldwide. Many patients now have legal access to products derived from cannabis. In the Middle East, Lebanon became the first Arab country to legalize cannabis for medical and industrial use recently in 2020. Other Middle Eastern and Arab countries continue to completely ban the use of cannabis and products derived from cannabis. This article is a call to conduct medical research in the use of cannabis for medical purposes to determine the suitability and need for this substance in the Arab world. Based on these studies, evidence-based recommendations can be made to the highest authorities in the Arab countries for legalization or continued prohibition. As the international use of cannabis is increasing, the Arab countries may consider legalization of the substance to cover the unmet medical need and offer an additional treatment option for certain conditions.

show abstract

Bridging the Accessibility Gap of Cannabinoid Medicine and Arabic Culture

Cited by 6 publications

References 9 publications

Foreign Medical Students in Eastern Europe: Knowledge, Attitudes and Beliefs about Medical Cannabis for Pain Management

Foreign Medical Students in Eastern Europe: Knowledge, Attitudes and Beliefs about Medical Cannabis for Pain Management

Cannabinoids in the Treatment of Epilepsy: A Review

The Use of Cannabis for Medical Purposes in the Arab World

Contact Info

Product

Resources

About